Abstract:Recently, molecular generation models based on deep learning have attracted significant attention in drug discovery. However, most existing molecular generation models have serious limitations in the context of drug design wherein they do not sufficiently consider the effect of the three-dimensional (3D) structure of the target protein in the generation process. In this study, we developed a new deep learning-based molecular generator, SBMolGen, that integrates a recurrent neural network, a Monte Carlo tree search, and docking simulations. The results of an evaluation using four target proteins (two kinases and two G protein-coupled receptors) showed that the generated molecules had a better binding affinity score (docking score) than the known active compounds, and the generated molecules possessed a broader chemical space distribution. SBMolGen not only generates novel binding active molecules but also presents 3D docking poses with target proteins, which will be useful in subsequent drug design. The code is available at <a class="extLink" href="https://github.com/clinfo/SBMolGen">https://github.com/clinfo/SBMolGen</a>.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.1c00679?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.1c00679</a>.Number of generated molecules, example of generated molecules for target EGFR at C = 1.0, example of generated molecules for target AA2AR at C = 1.0, example of generated molecules for target ADRB2 at C = 1.0; distribution of the similarity score of the generated molecules and distribution of the scaffold similarity score of the generated molecules; distribution of the SA scores of the generated molecules; distributions of the QED scores of the generated molecules; plots of IFIE<sub>sum</sub> against experimentally determined Δ<i>G</i> for (A) nine CDK2 inhibitors and (B) generated molecules; distribution of the docking scores of the generated molecules against DDR1; chemical structures of nine CDK2 inhibitors and their properties (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.1c00679/suppl_file/ci1c00679_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

NGT: Generative AI with Synthesizability Guarantees Discovers MC2R Inhibitors from a Tera-Scale Virtual Screen

NGT: Generative AI with Synthesizability Guarantees Identifies Potent Inhibitors for a G-protein Associated Melanocortin Receptor in a Tera-scale vHTS Screen

An efficient graph generative model for navigating ultra-large combinatorial synthesis libraries

DrugSynthMC: an atom based generation of drug-like molecules with Monte Carlo Search

Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning

ChemSpaceAL: An Efficient Active Learning Methodology Applied to Protein-Specific Molecular Generation

Generative artificial intelligence for small molecule drug design

Molecular Design in Synthetically Accessible Chemical Space via Deep Reinforcement Learning

Guided Multi-objective Generative AI to Enhance Structure-based Drug Design

DrugGen: Advancing Drug Discovery with Large Language Models and Reinforcement Learning Feedback

It Takes Two to Tango: Directly Optimizing for Constrained Synthesizability in Generative Molecular Design

ClickGen: Directed Exploration of Synthesizable Chemical Space Via Modular Reactions and Reinforcement Learning

Generative AI for Drug Discovery: A GPT-2 and LSTM Based Models for Designing EGFR Inhibitors

Optimization of binding affinities in chemical space with generative pre-trained transformer and deep reinforcement learning

ChemistGA: A Chemical Synthesizable Accessible Molecular Generation Algorithm for Real-World Drug Discovery

Structure-Based de Novo Molecular Generator Combined with Artificial Intelligence and Docking Simulations

Diversity oriented Deep Reinforcement Learning for targeted molecule generation

Target-specific novel molecules with their recipe: Incorporating synthesizability in the design process

Molecule generation toward target protein (SARS-CoV-2) using reinforcement learning-based graph neural network via knowledge graph

Generative chemistry: drug discovery with deep learning generative models